04:30 AM EDT, 03/20/2026 (MT Newswires) -- Seshadri Neervannan, Chief Operating Officer, on March 17, 2026, sold 11,324 shares in Tarsus Pharmaceuticals ( TARS ) for $772,444. Following the Form 4 filing with the SEC, Neervannan has control over a total of 86,255 common shares of the company, with 85,780 shares held directly and 475 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1819790/000182758426000009/xslF345X05/wk-form4_1773961468.xml